ArticleMolecular biology reports2026
PER3 expression in granulosa cells of women with polycystic ovary syndrome: a potential role of the ovarian peripheral clock in infertility.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPolycystic ovary syndrome (PCOS) is a common endocrine disorder associated with infertility, metabolic dysfunction, and circadian rhythms disturbances, including delayed melatonin secretion. The human Period3 (PER3) plays an important role in regulating tissue-specific peripheral circadian clock. This suggests that the PER3 may be an important component of the ovarian circadian clock and could contribute to PCOS pathogenesis. METHODS AND
resultsAt first, PCOS-related RNAseq studies retrieved from the GEO database and analyzed to find differential gene expression in PCOS datasets. In experimental step, follicular fluid and surrounding cumulus cells were collected from 16 PCOS patients and 12 healthy women. Isolated granulosa cells from follicular fluid were cultured in α-MEM supplemented with the addition of follicular fluid and harvested at 2-hour intervals over 12 h timepoints. PER3 gene expression was measured by real-time PCR. Melatonin and estrogen hormone concentrations in follicular fluid were measured using ELISA. Both RNA-seq and qPCR showed a significant increase in PER3 gene expression in PCOS patients compared to controls. Also, the normal oscillation patterns of PER3 were disrupted in PCOS patients. Melatonin and estrogen levels were significantly reduced in PCOS group.
conclusionOur findings suggest that increased PER3 gene expression and disruption of its rhythmicity in granulosa cells appear to be associated with PCOS. This circadian disruption may contribute to changes in melatonin and estrogen levels, potentially contributing to the development of PCOS symptoms.
Indexed as
Identifiers
41746518What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.